City of Edinburgh, Scotland, United Kingdom Funds with similar focus
| Fund Name | Location |
| Al Hamra Group | Ras Al Khaimah, Ras al-Khaimah, United Arab Emirates |
| Alive Ideas | France, Ile-de-France, Paris |
| Beijing Ronghui Tongda Touzi Quanli Youxian Gongsi | Beijing, China, Haidian |
| Bravos Capital | California, Los Angeles, United States |
| Burda International | Bayern, Germany, Munich |
| Calyon Financial | Chicago, Illinois, United States |
| Fang Fund Partners | Chaoyang, China, Liaoning |
| Fazer | Finland, Southern Finland, Vantaa |
| Information Capital LLC | New York, United States, Woodside |
| Jiadel Medical | - |
| MAR ventures | Brazil, São Paulo, Sao Paulo |
| Plains Angels | Des Moines, Iowa, United States |
| San Diego Venture Partners | - |
| SBS Ventures | - |
| Spark Growth Ventures | - |
| Tianhe Yongxin | Beijing, China, Haidian |
| Washington Technology Industry Association (WTIA) | Seattle, United States, Washington |
| Wenzhou Dongchuang Xinhui | - |
| Xinyu Zichan | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Recursion Pharmaceuticals | $121M | 15 Jul 2019 | Salt Lake City, Utah, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Recursion Pharmaceuticals | $121M | 15 Jul 2019 | Salt Lake City, Utah, United States |
